Creutzfeldt-Jakob disease overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 7: Line 7:
==Diagnosis==
==Diagnosis==
===Laboratory Findings===
===Laboratory Findings===
The diagnosis of CJD is suspected when there are typical clinical symptoms and signs such as rapidly progressing [[dementia]] with [[myoclonus]].  Analysis of CSF for [[14-3-3 protein]] is done to establish diagnosis.
The diagnosis of CJD is suspected when there are typical clinical symptoms and signs such as rapidly progressing [[dementia]] with [[myoclonus]].  Analysis of CSF for [[14-3-3 protein]] is done to establish diagnosis.<ref>{{Cite web  | last =  | first =  | title = https://www.aan.com/Guidelines/home/GetGuidelineContent/567 | url = https://www.aan.com/Guidelines/home/GetGuidelineContent/567 | publisher =  | date =  | accessdate = 14 February 2014 }}</ref>


==References==
==References==

Revision as of 15:36, 14 February 2014

Creutzfeldt-Jakob disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Creutzfeldt-Jakob disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Creutzfeldt-Jakob disease overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Creutzfeldt-Jakob disease overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Creutzfeldt-Jakob disease overview

CDC on Creutzfeldt-Jakob disease overview

Creutzfeldt-Jakob disease overview in the news

Blogs on Creutzfeldt-Jakob disease overview

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Creutzfeldt-Jakob disease overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Creutzfeldt-Jakob disease is a very rare and incurable degenerative neurological disorder (brain disease) that is ultimately fatal. Among the types of transmissible spongiform encephalopathy found in humans, it is the most common.[1]

Diagnosis

Laboratory Findings

The diagnosis of CJD is suspected when there are typical clinical symptoms and signs such as rapidly progressing dementia with myoclonus. Analysis of CSF for 14-3-3 protein is done to establish diagnosis.[2]

References

  1. "http://www.cdc.gov/ncidod/dvrd/cjd/". Retrieved 14 February 2014. External link in |title= (help)
  2. "https://www.aan.com/Guidelines/home/GetGuidelineContent/567". Retrieved 14 February 2014. External link in |title= (help)


Template:WikiDoc Sources